Probabilistic application of a fugacity model to predict triclosan fate during wastewater treatment

The fate and partitioning of the antimicrobial compound, triclosan, in wastewater treatment plants (WWTPs) is evaluated using a probabilistic fugacity model to predict the range of triclosan concentrations in effluent and secondary biosolids. The WWTP model predicts 84% to 92% triclosan removal, which is within the range of measured removal efficiencies (typically 70% to 98%). Triclosan is predominantly removed by sorption and subsequent settling of organic particulates during primary treatment and by aerobic biodegradation during secondary treatment. Median modeled removal efficiency due to sorption is 40% for all treatment phases and 31% in the primary treatment phase. Median modeled removal efficiency due to biodegradation is 48% for all treatment phases and 44% in the secondary treatment phase. Important factors contributing to variation in predicted triclosan concentrations in effluent and biosolids include influent concentrations, solids concentrations in settling tanks, and factors related to solids retention time. Measured triclosan concentrations in biosolids and non-United States (US) effluent are consistent with model predictions. However, median concentrations in US effluent are over-predicted with this model, suggesting that differences in some aspect of treatment practices not incorporated in the model (e.g., disinfection methods) may affect triclosan removal from effluent. Model applications include predicting changes in environmental loadings associated with new triclosan applications and supporting risk analyses for biosolids-amended land and effluent receiving waters.

[1]  H. Singer,et al.  Triclosan: occurrence and fate of a widely used biocide in the aquatic environment: field measurements in wastewater treatment plants, surface waters, and lake sediments. , 2002, Environmental science & technology.

[2]  T. Federle,et al.  Fate and effects of triclosan in activated sludge , 2002, Environmental toxicology and chemistry.

[3]  R. Halden,et al.  Mass balance assessment of triclosan removal during conventional sewage treatment. , 2007, Chemosphere.

[4]  Glen R. Boyd,et al.  Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. , 2003, The Science of the total environment.

[5]  K. Bester.  Fate of Triclosan and Triclosan-Methyl in Sewage TreatmentPlants and Surface Waters , 2005, Archives of environmental contamination and toxicology.

[6]  Donald Mackay,et al.  Multimedia Environmental Models: The Fugacity Approach, Second Edition , 2001 .

[7]  R. Reiss,et al.  An ecological risk assessment for triclosan in lotic systems following discharge from wastewater treatment plants in the United States , 2002, Environmental toxicology and chemistry.

[8]  R. Trussell,et al.  International report: water and wastewater disinfection - trends, issues and practices , 2002 .

[9]  D. Sabaliūnas,et al.  Environmental fate of Triclosan in the River Aire Basin, UK. , 2003, Water research.

[10]  Philip H. Howard,et al.  Computer estimation of the Atmospheric gas-phase reaction rate of organic compounds with hydroxyl radicals and ozone , 1993 .

[11]  Richard M. Dinsdale,et al.  The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. , 2009, Water research.

[12]  E. Furlong,et al.  Survey of organic wastewater contaminants in biosolids destined for land application. , 2006, Environmental science & technology.

[13]  Daniel Mamais,et al.  Investigation of triclosan fate and toxicity in continuous-flow activated sludge systems. , 2007, Chemosphere.

[14]  Kurtis Sarafin,et al.  Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. , 2006, The Science of the total environment.

[15]  H. Takada,et al.  Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. , 2006, Water research.

[16]  Armin Hauk,et al.  Measurement of triclosan in wastewater treatment systems , 2002, Environmental toxicology and chemistry.

[17]  W. Shelver,et al.  Measurement of triclosan in water using a magnetic particle enzyme immunoassay. , 2007, Journal of agricultural and food chemistry.

[18]  A. Fernández-Alba,et al.  Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. , 2007, Chemosphere.

[19]  H. Kroiss,et al.  The solids retention time-a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. , 2005, Water research.

[20]  A. D. A. K I N N E Y,et al.  Survey of Organic Wastewater Contaminants in Biosolids Destined for Land Application † , 2006 .

[21]  S. Snyder,et al.  Removal of endocrine disruptors and pharmaceuticals during water treatment , 2007 .

[22]  Guang-Guo Ying,et al.  Triclosan in wastewaters and biosolids from Australian wastewater treatment plants. , 2007, Environment international.

[23]  N. Paxéus.  Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. , 2004, Water science and technology : a journal of the International Association on Water Pollution Research.

[24]  B. Venables,et al.  Triclosan in a North Texas wastewater treatment plant and the influent and effluent of an experimental constructed wetland , 2006, Environmental toxicology and chemistry.

[25]  G. Foster,et al.  Tracking acidic pharmaceuticals, caffeine, and triclosan through the wastewater treatment process , 2005, Environmental toxicology and chemistry.

[26]  Michael Matthies,et al.  Selecting internally consistent physicochemical properties of organic compounds , 2002, Environmental toxicology and chemistry.

[27]  Gary E. Blau,et al.  Environmental Exposure From Chemicals , 1985 .

[28]  Sayed R Qasim.  Wastewater Treatment Plants: Planning, Design and Operation , 1986 .

[29]  R. Stuetz,et al.  The Fate and Removal of Triclosan during Wastewater Treatment , 2005, Water environment research : a research publication of the Water Environment Federation.

[30]  Daniel Mamais,et al.  Application of the OECD 301F respirometric test for the biodegradability assessment of various potential endocrine disrupting chemicals. , 2008, Bioresource technology.

[31]  Jennifer Lyndall,et al.  Probabilistic risk evaluation for triclosan in surface water, sediments, and aquatic biota tissues , 2010, Integrated environmental assessment and management.

[32]  Anton Lindström,et al.  Occurrence and environmental behavior of the bactericide triclosan and its methyl derivative in surface waters and in wastewater. , 2002, Environmental science & technology.

[33]  Adriano Joss,et al.  Scrutinizing pharmaceuticals and personal care products in wastewater treatment. , 2004, Environmental science & technology.

[34]  K. Bester.  Triclosan in a sewage treatment process--balances and monitoring data. , 2003, Water research.

[35]  R. Hale,et al.  Organic Contaminants of Emerging Concern in Land-Applied Sewage Sludge (Biosolids) , 2004 .

[36]  Jennifer Lyndall,et al.  Terrestrial ecological risk evaluation for triclosan in land‐applied biosolids , 2010, Integrated environmental assessment and management.

[37]  D Mackay,et al.  Fugacity analysis and model of organic chemical fate in a sewage treatment plant. , 1995, Environmental science & technology.

[38]  Frank R. Spellman,et al.  Handbook of Water and Wastewater Treatment Plant Operations , 2003 .